Beijing Pearl Biotechnology Limited Liability Company;Beijing Neurosurgical Institute
发明人:
申请号：
EP16881038.0
公开号：
EP3398949A1
申请日:
2016.12.21
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention provides uses of a compound represented by formula A in the preparation of drugs for treating brain glioma and particularly glioblastoma. Particularly provided are uses of the compound represented by formula A in the preparation of drugs for treating expression of specific fusion protein. By means of the technical solution of the present invention, typing of brain glioblastoma can be implemented, a drug administration can be carried out for a specific patient group, and precise treatment can be implemented.
